Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Synthetic glucagon analogue modified to contain 7 amino acid substitutions

EU orphan designation number: EU/3/17/1887   
Active ingredient: Synthetic glucagon analogue modified to contain 7 amino acid substitutions
Indication: Treatment of congenital hyperinsulinism
Sponsor: Zealand Pharma A/S
Smedeland 36, 2600 Glostrup, Denmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/06/2017 Orphan designation EMA/OD/002/17 (2017)4373 of 20/06/2017